Effects of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide on blood-brain barrier and dopaminergic neurons of rats with lipopolysaccharide-induced Parkinson's disease (Q48859939)

From Wikidata

Jump to navigation Jump to search

scientific article published on 20 November 2013

Language	Label	Description	Also known as
English	Effects of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide on blood-brain barrier and dopaminergic neurons of rats with lipopolysaccharide-induced Parkinson's disease	scientific article published on 20 November 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24254220

Effects of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide on blood-brain barrier and dopaminergic neurons of rats with lipopolysaccharide-induced Parkinson's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24254220

lipopolysaccharide

1 reference

based on heuristic

inferred from title

blood–brain barrier

1 reference

based on heuristic

inferred from title

author name string

Xiao-li Wu

1

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24254220

Ping Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24254220

Yun-hui Liu

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24254220

Yi-xue Xue

4

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24254220

publication date

20 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24254220

Journal of Molecular Neuroscience

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24254220

53

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24254220

1

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24254220

1-9

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24254220

6-Hydroxydopamine-induced alterations in blood-brain barrier permeability

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Lycopene suppresses LPS-induced NO and IL-6 production by inhibiting the activation of ERK, p38MAPK, and NF-kappaB in macrophages

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Nuclear ADP-ribosylation reactions in mammalian cells: where are we today and where are we going?

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Anti-inflammatory effects of dichloromethane fraction from Orostachys japonicus in RAW 264.7 cells: suppression of NF-κB activation and MAPK signaling.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Effect of acute poly(ADP-ribose) polymerase inhibition by 3-AB on blood-brain barrier permeability and edema formation after focal traumatic brain injury in rats.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Expression of the histocompatibility glycoprotein HLA-DR in neurological disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Poly(ADP-ribose)polymerase 1 (PARP-1) and postischemic brain damage

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Blood-brain barrier disruption induces in vivo degeneration of nigral dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Effects of bacterial toxins on endothelial tight junction in vitro: a mechanism-based investigation

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Effects of chronic ethanol drinking on the blood brain barrier and ensuing neuronal toxicity in alcohol-preferring rats subjected to intraperitoneal LPS injection

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Inflammation as a causative factor in the aetiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Lipopolysaccharide stimulates syntheses of toll-like receptor 2 and surfactant protein-A in human alveolar epithelial A549 cells through upregulating phosphorylation of MEK1 and ERK1/2 and sequential activation of NF-κB.

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice

1 reference

https://api.crossref.org/works/10.1007%2FS12031-013-0175-5

21 January 2018

Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24254220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system

1 reference

https://pubmed.ncbi.nlm.nih.gov/24254220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Poly(ADP-ribose)polymerase inhibitor can attenuate the neuronal death after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/24254220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum

1 reference

https://pubmed.ncbi.nlm.nih.gov/24254220

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12031-013-0175-5

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24254220

release_34jnkz3gsffovgmjkfxhmpa2c4

1 reference

https://api.fatcat.wiki/v0/release/34jnkz3gsffovgmjkfxhmpa2c4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/24254220

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48859939&oldid=2212489828"